| Dr Amy Sanderson, OD | |
|
102 Intercom Drive, Madison, AL 35758-2638 | |
| (256) 772-2929 | |
| (256) 772-2928 |
| Full Name | Dr Amy Sanderson |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 23 Years |
| Location | 102 Intercom Drive, Madison, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669477824 | NPI | - | NPPES |
| 102G700010 | Other | PTAN FOR ADVANCED EYECARE OF MADISON | |
| 102G700010 | Other | PTAN FOR ADVANCED EYECARE OF MADISON FOR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | S-997-TA-564 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Eyecare Of Madison, P.c. | 9638389463 | 2 |
News Archive
A new Portland State study challenges the idea that youth with cognitive disabilities are unable or lack potential to pursue a career in science, technology, engineering and mathematics.
Corus Pharma announced yesterday that it has been selected as a member of FierceBiotech's annual "The Fierce 15." FierceBiotech Editor-in-Chief John D. Carroll observed "We applaud Corus' ongoing commitment to increasing the quality of life for people living with cystic fibrosis."
New research findings may help physicians determine which women have an increased risk of blood clots when taking tamoxifen for the management of breast cancer, a team led by Dana-Farber Cancer Institute investigators will report at the American Society of Clinical Oncology's annual meeting.
A large study of intensive care patients in California found that public reporting of patient outcomes did not reduce mortality, but did result in reduced admission of the sickest patients to the ICU and increased transfer of critically ill patients to other hospitals.
› Verified 7 days ago
| Provider Name | Advanced Eyecare Of Madison, P.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1548265705 PECOS PAC ID: 9638389463 Enrollment ID: O20110106001046 |
News Archive
A new Portland State study challenges the idea that youth with cognitive disabilities are unable or lack potential to pursue a career in science, technology, engineering and mathematics.
Corus Pharma announced yesterday that it has been selected as a member of FierceBiotech's annual "The Fierce 15." FierceBiotech Editor-in-Chief John D. Carroll observed "We applaud Corus' ongoing commitment to increasing the quality of life for people living with cystic fibrosis."
New research findings may help physicians determine which women have an increased risk of blood clots when taking tamoxifen for the management of breast cancer, a team led by Dana-Farber Cancer Institute investigators will report at the American Society of Clinical Oncology's annual meeting.
A large study of intensive care patients in California found that public reporting of patient outcomes did not reduce mortality, but did result in reduced admission of the sickest patients to the ICU and increased transfer of critically ill patients to other hospitals.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amy Sanderson, OD 102 Intercom Drive, Madison, AL 35758-2638 Ph: (256) 772-2929 | Dr Amy Sanderson, OD 102 Intercom Drive, Madison, AL 35758-2638 Ph: (256) 772-2929 |
News Archive
A new Portland State study challenges the idea that youth with cognitive disabilities are unable or lack potential to pursue a career in science, technology, engineering and mathematics.
Corus Pharma announced yesterday that it has been selected as a member of FierceBiotech's annual "The Fierce 15." FierceBiotech Editor-in-Chief John D. Carroll observed "We applaud Corus' ongoing commitment to increasing the quality of life for people living with cystic fibrosis."
New research findings may help physicians determine which women have an increased risk of blood clots when taking tamoxifen for the management of breast cancer, a team led by Dana-Farber Cancer Institute investigators will report at the American Society of Clinical Oncology's annual meeting.
A large study of intensive care patients in California found that public reporting of patient outcomes did not reduce mortality, but did result in reduced admission of the sickest patients to the ICU and increased transfer of critically ill patients to other hospitals.
› Verified 7 days ago
Dr. Ashley Wright, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8521 Highway 72 W, Madison, AL 35758 Phone: 256-461-8800 | |
Dr. James Tion Lim, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 540 Hughes Rd, Suite 11, Madison, AL 35758 Phone: 256-772-4005 Fax: 256-772-5999 | |
Acute Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 8089 Highway 72 W, Suite A, Madison, AL 35758 Phone: 256-325-9465 Fax: 256-325-9467 | |
Jagani Vision Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 106 Walking Trail Way, Madison, AL 35758 Phone: 205-792-6602 | |
Ardmore Eye Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7771 Highway 72 W, Suite D, Madison, AL 35758 Phone: 256-430-1700 Fax: 256-830-5132 | |
Specs Of Madison Optometrist Medicare: Not Enrolled in Medicare Practice Location: 21 Hughes Rd, Madison, AL 35758 Phone: 256-246-2969 Fax: 256-767-7374 | |
Dr. David S Parker, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 66 Hughes Rd, Madison, AL 35758 Phone: 256-461-7100 Fax: 256-461-7101 |